DalsnaFinance › IPOs › Lb Pharmaceuticals Inc › IPO
LB PHARMACEUTICALS INC completed its initial public offering on NASDAQ on September 11, 2025, pricing at $15.00 a share.
| Ticker | LBRX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 11, 2025 |
| Offering price | $15.00 |
| Shares offered | 19,000,000 |
| Total raised | $285M |
LB PHARMACEUTICALS INC sold 19,000,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $285 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $285 million total recorded for the deal.
Measured by money raised, LB PHARMACEUTICALS INC was the 102nd largest of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 342 listings on NASDAQ alone, it is the 58th largest.
September 2025 saw 28 completed IPOs in the site's data; by amount raised, LB PHARMACEUTICALS INC was the 14th largest of the 28 deals with a recorded size.
Its $15.00 offer price was tied for the 122nd highest (level with 8 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
LB PHARMACEUTICALS INC — quote, profile and latest news →
Source: SEC EDGAR filings for LB PHARMACEUTICALS INC. This page is general information, not investment advice.